The FDA-centric Australian CRO championing innovative US and global biotech firms. 

Delivering high quality clinical research at a fraction of the cost.
Find out more

Recently featured in

Why do so many US and global biotech firms bring their early-stage clinical trials to Australia?

home page icons_govt grant access icon
Government Grant Access

43.5% Government R&D tax incentive (even for foreign companies)

home page icons_fast quality research icon
Fast, High-Quality Research

Fast start-up time without sacrificing quality – 8-12 weeks on average (no IND required)

home page icons_regulatory expertise icon
FDA Regulatory Expertise

iNGENū's in-house regulatory team specializes in US FDA Pre-INDs and IND submissions

home page icons_therapeutic leaders icon
Diverse Therapeutic Specialty Leaders

Our team comprises physician and scientific specialists in a wide variety of areas

 

Our trusted partners

Our Mission

Our core mission is to create access to high quality clinical research globally by removing financial and other unnecessary barriers.

 

doctor-homepage

"We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have used iNGENū for: Medical writing, project management, clinical data management and full end-to-end, clinical trial execution and monitoring.
We have been very happy with all aspects of the management of the clinical trial and have been particularly impressed by the out-of-the-box creative solutions to speed up and reduce overheads for our company during this clinical trial."

Giles Moss
Chief Executive Officer

iNGENu testimonial-logos-monotone-1

Meet our Clinical
Leadership Team

About us